JPRN-UMIN000020110
Completed
N/A
Dexmedetomidine for sedation during endoscopic submucosal dissection of early gastrointestinal lesion - Dexmedetomidine for endoscopic submucosal dissection
Medical corporation Yamashita Hospital0 sites100 target enrollmentJanuary 1, 2016
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- early esophageal, gastric, duodenal and colorectal cancer or dysplasia
- Sponsor
- Medical corporation Yamashita Hospital
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Cases with severe complications are excluded.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
sefulness of dexmedetomidine for endoscopic submucosal dissection in colocolorectal tumorJPRN-UMIN000021769Hiroshima City Hiroshima Citizens Hospital80
Completed
N/A
A Comparison of Efficacy and Safety During Endoscopic Submucosal Dissection Between Dexmedetomidine-remifentanil and Propofol-remifentanilEarly Gastric Cancer Patients Who Were Scheduled for Endoscopic Submucosal DissectionNCT01920113Yonsei University60
Not Yet Recruiting
N/A
Study the effect of Dexmedetomidine Drug in preventing Confusional State and agitation that occurs in patients undergoing urological surgery under general anaesthesia.Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary systemCTRI/2021/09/036789Institutional Review Board IRB
Completed
Phase 4
study the effectiveness of dexmedetomidine, a drug,given before start of surgery by anesthetist, in preventing increase in blood pressure and pulse rate which generally occurs at that time and can result in dangerous arrhythmias and heart attackCTRI/2011/10/002046Swai Maan singh Medical College and Attached hospital100
Completed
Phase 2
Dexmedetomidine sedation in awake caudal block for lower abdominal surgeries in neonatesIRCT20190114042358N3Tabriz University of Medical Sciences100